Although the article presents some interesting new findings regarding mammogram for women in their 40s, the article lacks a strong critical analysis to point out the weaknesses with the current study.
Since the U.S. Preventive Services Task Force published their revised recommendations in November of 2009, many women between the ages of 40-49 have continued to be confused about what the evidence shows and what they should do.
News organizations that continue to report each new study on one side of the debate or the other should try to dedicate a considerable chunk of the story to an info-graphic or fact box to guide shared decision-making.
No discussion of costs regarding mammograms. Stories should not assume that every woman in the 40s who chooses to get a mammogram will have this covered by their insurance.
We’ll give the story the benefit of the doubt for presenting lots of numbers – in contrast with the WebMD story that included NONE.
However, more critical analysis would have been appreciated.
The story did discuss why mammography in younger women is not always beneficial and described several of the harms that the US Preventive Services Task Force discussed.
The article never pointed out that this was NOT a randomized controlled trial. The article also should have discussed:
The article did interview the chair of the U.S. Preventive Services Task Force (USPSTF).
In allowing Dr. Virginia Moyer of the USPSTF to talk about the need for women “to make their own decision,” the story at least implies that declining screening is a choice. It could have been far more overt, but we’ll give the story the benefit of the doubt that the alternative choice was at least implied.
Not applicable. Availability of mammograms is not in question although access to care is dependent upon many factors including distance to facility with instrument, insurance coverage, etc.
The story at least acknowledged some past studies in the ongoing debate about “the best age to start routine mammograms and the best screening interval.”
It appears that the story did not rely solely on a news release.
Systematic, Criteria-Driven
The tale of two “negative” studies. Or, how spin is applied to make research findings look more impressive. A must read. https://johnmandrola.substack.com/p/the-tale-of-two-negative-studies
The @nytimes chose to interview one of the editors of the @AnnalsofIM (publisher of this paper) who "gushed with extraordinary glee: It’s huge! There are very few things that reduce your mortality by 30%."
Turns out coffee is not one of those few things despite all that glee. https://twitter.com/garyschwitzer/status/1533202075928215558
Comments (2)
Please note, comments are no longer published through this website. All previously made comments are still archived and available for viewing through select posts.
Stacey Vitiello, MD
February 28, 2012 at 9:09 pmThe single most common cause of death for women age 35 to 50 is breast cancer. I’ve commented on this new study, and on the most appropriate age to begin screening mammography, here: http://staceyvitiellomd.com/2012/02/first-do-no-harm-the-spectacular-failure-of-a-government-panel/
Jessica Schwartz
February 29, 2012 at 12:53 pmThe study concludes that “less treatment” rather than “overall suvival” should be the new criteria for judging the merits of mammograms. Since treatment now has more to do with the biology of the cancer rather than the stage at diagnosis, this conclusion has no merits. My personal experience with mammograms is that I had a suspicious mammogram in 2003, which was subsequently biopsied (stereotactic) in 2005. The biopsy was from the wrong spot–yielded a benign result. Had 2 mammograms per year for 5 yrs (because of dense breasts–which I was not notified about (ties into your article about informing patients). Radiolgists watched calcifications grow and spread assuming it was benign because of the 2005 finding. Another stereo in 2010 (again from the wrong spot) came back DCIS covering most of my breast. Mastectomy and sentinel node revealed 8mm metatasis is sentinel node. Path discovered 2.5cm invasive tumor. (by the way I had an MRI before surgery and the radioligist recorded a 3 cm mass, but concluded that it was consistent with “biopsy proven DCIS.” So I wound up with stage 2b IDC even though I had mammograms from age 40 and minum of 2 mammos per year from age 45. I was told by my first onc that I needed chemo. After she violated HIPPA (gave my contact info to a university to ask me questions about how financial decisions impact my medical choices–also ties into your article on patient information) -I sought a second opinion and asked for oncotypeDX (even though I was node positive 1 of 12). That test revealed that chemo would only reduce my risk of recurrence by 2-5%. I took a pass on chemo. So my risk of recurrence is high but the more agressive treatment would not have treated my ER positive breast cancer. It is imperitive to inform women with dense breasts that Mammograms are not for them. Further, women with gene mutations such as BRCA and others that lead to breast cancer should also avoid over exposure to ionized radiation. I was diagnosed 2 years ago. I have had NO peace because I can not trust my doctors and because I have constantly had to dictate my own care. A lot of the arguments against early mammograms is that it leads to overtreatment because of false positives. But how about all the cancers that mammos do not detect? The only thing mammos are good at is detecting DCIS. In my case, the technology did detect it, but the doctors made a lot of erroneous asumptions at my expense. Mammograms DO NOT SAVE LIVES, nor are they responsible for “less treatment.” I had a bilateral mastectomy, bilateral oophorectomy and am on an aromatase inhibitor which but for semantics is a slightly less toxic chemotherapy.
Our Comments Policy
But before leaving a comment, please review these notes about our policy.
You are responsible for any comments you leave on this site.
This site is primarily a forum for discussion about the quality (or lack thereof) in journalism or other media messages (advertising, marketing, public relations, medical journals, etc.) It is not intended to be a forum for definitive discussions about medicine or science.
We will delete comments that include personal attacks, unfounded allegations, unverified claims, product pitches, profanity or any from anyone who does not list a full name and a functioning email address. We will also end any thread of repetitive comments. We don”t give medical advice so we won”t respond to questions asking for it.
We don”t have sufficient staffing to contact each commenter who left such a message. If you have a question about why your comment was edited or removed, you can email us at feedback@healthnewsreview.org.
There has been a recent burst of attention to troubles with many comments left on science and science news/communication websites. Read “Online science comments: trolls, trash and treasure.”
The authors of the Retraction Watch comments policy urge commenters:
We”re also concerned about anonymous comments. We ask that all commenters leave their full name and provide an actual email address in case we feel we need to contact them. We may delete any comment left by someone who does not leave their name and a legitimate email address.
And, as noted, product pitches of any sort – pushing treatments, tests, products, procedures, physicians, medical centers, books, websites – are likely to be deleted. We don”t accept advertising on this site and are not going to give it away free.
The ability to leave comments expires after a certain period of time. So you may find that you’re unable to leave a comment on an article that is more than a few months old.
You might also like